Diagnosing the Bladder as the Source of Pelvic Pain: Successful Treatment for Adults and Children

Pain management · 2014 · vol. 4(4) , pp. 293–301 · doi:10.2217/pmt.14.21 · PMID:25300387 · W2054594576
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

Interstitial cystitis, characterized by bladder epithelium dysfunction, is frequently misdiagnosed but can be successfully treated in over 90% of patients using multimodal drug therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The key to successful therapy of interstitial cystitis (IC) is to correctly diagnose it. The significant majority of patients with IC have a dysfunctional bladder epithelium that allows urinary solutes (primarily potassium) to leak into the bladder wall, causing symptoms and tissue damage. Drugs that correct this dysfunction and suppress symptoms are important to achieve successful outcomes in patients. Today over 95% of females with IC are misdiagnosed as having gynecologic chronic pelvic pain, vulvodynia, vaginitis, endometriosis, overactive bladder or urinary tract infection. Men are misdiagnosed as having prostatitis. Often children are not diagnosed at all. Multimodal drug therapy may be required and can achieve successful resolution of IC in over 90% of patients. IC in children can be treated successfully with pentosan polysulfate.

My notes (saved in your browser only)

Condition tags

chronic_pelvic_painendometriosisinterstitial_cystitis

MeSH descriptors

Cystitis, Interstitial Cystitis, Interstitial Pain Management Pelvic Pain Age Factors Cystitis, Interstitial Female Humans Male Pelvic Pain Treatment Outcome

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (59)

Source provenance

europepmc
last seen: 2026-09-10T06:15:44.054944+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:18:15.805398+00:00
License: CC0 · commercial use OK